Bitcoin Bull Case: Semler Scientific’s Treasury Bet Could Still Deliver 300% Gains, Says Benchmark

Wall Street's latest crypto-infused fever dream just got a bullish steroid shot. Semler Scientific—the medical tech firm turned Bitcoin treasury guinea pig—still has triple-digit upside, according to Benchmark analysts.

From Blood Pressure Cuffs to BTC Balance Sheets

Once known for vascular testing gear, Semler morphed into a crypto darling after allocating chunks of its reserves to Bitcoin. Now analysts argue the market hasn't priced in its asymmetric bet on digital gold.

The 3X Factor

Benchmark's price target implies a 200% premium to current levels—a gamble that'd make even Cathie Wood blush. 'Either they're geniuses ahead of the institutional curve,' quipped one trader, 'or another case study for MBA students on speculative excess.'

As traditional finance scrambles to reconcile Bitcoin's volatility with corporate treasury 'best practices,' Semler's all-in move keeps dividing Wall Street. One thing's certain: their earnings calls just got way more interesting than medical supply margins.